CLOS
ABBV icon

Compagnie Lombard Odier SCmA’s AbbVie ABBV Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-76,200
Closed -$26K – 597
2017
Q4 		$26K Buy
76,200
+41,200
+118% +$3.88M ﹤0.01% 569
2017
Q3 		$101K Buy
+35,000
New +$2.66M ﹤0.01% 436
2016
Q4 		– Sell
-7,100
Closed -$24K – 808
2016
Q3 		$24K Buy
+7,100
New +$460K ﹤0.01% 772

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Compagnie Lombard Odier SCmA's ABBV Position: Q1 2026 in Review

Compagnie Lombard Odier SCmA reduced its AbbVie (ABBV) stake by 4.1% in Q1 2026, selling an estimated $2.91M and leaving 309,351 shares worth $67.3M. The position accounts for 0.83% of the portfolio, ranked #29.

Compagnie Lombard Odier SCmA first reported a position in ABBV in Q4 2013 and has held it in 50 quarters since. The position peaked at $285M in Q4 2017. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Compagnie Lombard Odier SCmA held 309,351 shares of AbbVie worth $67.3M as of Q1 2026.
  • Compagnie Lombard Odier SCmA sold 13,113 AbbVie shares in Q1 2026, an estimated $2.91M.
  • AbbVie made up 0.83% of Compagnie Lombard Odier SCmA's portfolio in Q1 2026, its #29 holding.
  • Compagnie Lombard Odier SCmA first reported a position in AbbVie in Q4 2013 and has held it in 50 quarters since.
  • Compagnie Lombard Odier SCmA's AbbVie position peaked at $285M in Q4 2017.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2026, filed 15 Apr 2026.